Seminars in Arthritis and Rheumatism

Article	Citations
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis	102
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study	93
Response letter to the editor	83
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	60
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder	56
mRNA vaccines in the rheumatologist's future	56
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	54
Response to the correspondence by Xu et al. regarding "Toward a more actionable RA-ILD risk model"	47
Metabolomics in systemic lupus erythematosus: A systematic review and meta-analysis	45
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial	45
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]	43
Immunotherapy in cancer	43
Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features	42
Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival	42
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort	41
Correspondence to ‘Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors’	40
Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts	40
Exploring the association between adiposity, pain intensity, and effusion-synovitis in people with knee osteoarthritis: A cross-sectional study	40
A clue for subclinical CNO in adolescents with acne conglobata and hidradenitis suppurativa: Persistan acute phase rectans elevation	38
Refining RA-ILD screening: Diagnostic limitations and the emerging role of lung ultrasound	37
Systemic sclerosis-related digital ulcers: Current understanding and updated management approaches- a primer for clinicians	36
HIF-1α in Gout: A central regulator of metabolism, inflammation, and environmental stress	36
Evaluation of disease severity and treatment responses in patients with enthesitis-related arthritis	35
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment	34
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments	34

Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances	33
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	33
Incidence of malignancy in systemic sclerosis: A systematic review and meta-analysis	33
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	33
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance	32
The Autoantibody response in rheumatoid arthritis; what makes it unique?	32
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?	32
Co-occurrence of rheumatoid arthritis and calcium pyrophosphate deposition disease: A systematic literature review	31
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?	31
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial	30
A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada	29
Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis	29
Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.	29
Corrigendum to “The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time” [Seminars in Arthritis and Rheumatism 55 (2022):152010]	28
Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease	28
Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study	28
Response to: Comment to “Vitamin D in psoriatic arthritis—A systematic review and meta-analysis”	28
Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study	28
Is there room for precocious prevention in rheumatoid arthritis precision medicine? A temporal and stratified reframing in diagnostic and therapeutic pathway	28
Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials	27
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	27
Longitudinal changes on cranial magnetic resonance imaging in relapsing giant cell arteritis	27
Response to Chen and Liu regarding correspondence to “Development of a prediction model for progression of rheumatoid arthritis–associated interstitial lung disease using serologic and clinical factor	26
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis	26
Raynaud's phenomenon secondary to central nervous system stimulants: A therapeutic role of α-1 adrenergic blockers?	26
The state of the Osteoarthritis Initiative (OAI): Entering a new era	25
Correspondence on “Central sensitization has major impact on quality of life in patients with axial spondyloarthritis” By Kieskamp et al.	25
A cohort study on the associations between age at natural menopause and rheumatoid arthritis in postmenopausal women from the Canadian Longitudinal Study on Aging	25
AA amyloidosis in inflammatory joint diseases: A systematic review	24
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry	24
Sodium-glucose cotransporter 2 (SGLT2) inhibition and autoimmunity	24
Prevalence of crystal deposits in asymptomatic hyperuricemia according to different scanning definitions: A comparative study	24
The clinical features of juvenile dermatomyositis: A single-centre inception cohort	24
Targeting the Wnt pathway for the treatment of Osteoarthritis of the knee	24
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis	24
Psychological stress in rheumatoid arthritis: a systematic scoping review	24
Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis	23
Response to commentary on IgG4-related uveitis. A French cohort and literature review	23
Trabecular bone score in glucocorticoid-induced osteoporosis: A systematic review and meta-analysis	23
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial	23
Therapeutic approach to central nervous system involvement of Behçet's disease	22
Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis	22
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofaciti	22
Looking at fibromyalgia differently – An observational study of the meaning and consequences of fibromyalgia as a dimensional disorder	22
Defining a personalized treatment approach to rheumatoid arthritis: Using genetic markers of TNFi response	21
Causal association of diet-derived circulating antioxidants with the risk of rheumatoid arthritis: A Mendelian randomization study	21
Response: Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed. Reply letter to Ciro Manzo (letter to the edit	21
Mechanisms of joint pain: Five short lessons from osteoarthritis	21
Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial	21
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients	20

Pathogenesis and targets in uveitis	20
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing	20
Further expanding the clinical spectrum of giant cell arteritis: Non-classical organ involvement and uncommon complications	20
HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up	20
Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of	19
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis	19
Discriminating capacity of the ASAS health index in patients with axial spondyloarthritis treated with ixekizumab	19
Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?	19
Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis	19
Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution	18
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review	18
The role of sex and systemic inflammation in the development of cardiovascular disease in osteoarthritis: A population-based cohort study using the CLSA	18
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial	18
Response to letter to the editor regarding "Nailfold Capillaroscopy as a predictor of cardiovascular events and mortality in systemic sclerosis"	18
Molecular mechanisms underlying thrombosis in systemic lupus erythematosus – A Systematic review	18
Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis	18
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseases	18
Sarcoidosis incidence after mTOR inhibitor treatment	18
Advances in Targeted Therapies (ATT) What's cooking in the academic's kitchen? 3TR (IMI)	17
Comment on: Miedany et al. Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure	17
Biologics in peripheral ulcerative keratitis	17
Association between Kawasaki disease and subsequent autoimmune disease: National cohort study of adolescents with 12-year follow-up from birth	17
CLINICAL CHARACTERISTICS OF PATIENTS WITH ANTISYNTHETASE SYNDROME AND DERMATOMYOSITIS-TYPE SKIN INVOLVEMENT: INSIGHTS FROM THE MYO-SPAIN REGISTRY	17
Autonomic dysfunction symptoms in Sjögren’s Disease: A missed dimension linked to disease burden and work disability	17
Juvenile and adult-onset scleroderma: Different clinical phenotypes	17
The control group matters: Pain, physical function and strength improvements relative to the comparator intervention in knee and hip osteoarthritis	17
CAR T-cell therapy in SLE: A systematic review	17
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis	17
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women	17
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis	16
Synovial fibroblasts in juvenile idiopathic arthritis: A scoping review	16
Response to: ‘Critical Commentary ‘Infectious complications of Belimumab with standard care in systemic lupus erythematosus: A systematic review and meta-analysis’ by Saketh Sainag Mandiga et al	16
Comments on the article by Goldman et al.	16
Correspondence to 'Nailfold capillaroscopy as a predictor of major cardiovascular events and mortality in systemic sclerosis'	16
Effects of neuromuscular control and strengthening exercises on MRI-measured thigh tissue composition and muscle properties in people with knee osteoarthritis – an exploratory secondary analysis from	16
Comparison between rheumatoid arthritis with malignant lymphoma and other malignancies: Analysis of a National Database of Rheumatic Disease in Japan	16
Paraproteinemias in Sjögren disease: cryoglobulinemia and serum monoclonal gammopathy identify distinct clinical phenotypes and differential lymphoma susceptibility	16
Re: comment on: Miedany et al. response letter: Beyond the symptoms: personalizing giant cell arteritis care through multidimensional patient reported outcome measure. Volume 75, December 2025, 152844	16
Epidemiology and clinical characteristics of polyarteritis nodosa in Japan: findings from a nationwide survey	16
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis	16
Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al	15
Definitions and online reliability assessment of elementary ultrasound lesions in Takayasu arteritis: a study from the OMERACT Ultrasound Working Group	15
Response to letter concerning article entitled "Central sensitization has major impact on quality of life in patients with axial spondyloarthritis	15
Predicting anxiety and depression in systemic lupus erythematosus: the role of inflammation, sociodemographic variables and clinical factors	15
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage	15
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis	15
MRI and Ultrasound in giant cell arteritis: complementary strengths and combined diagnostic value	15
Reply on: International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia	15
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitis	15
Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up	15
Modelling long-term outcomes for patients with systemic lupus erythematosus	15
Epicardial fat as a cardiovascular risk factor in inflammatory arthritis	15
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world da	15
Unraveling the role of neutrophil extracellular traps in rheumatoid arthritis: From triggers to therapeutic targets	14
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets	14
Response to the letter entitled " Letter to the editor to Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis" by Ga	14
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group	14
Acknowledgement of Referees	14
Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies	14
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group	14
Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis	14
Erratum to “Magnetic resonance imaging for adult idiopathic inflammatory myopathies: a scoping review of protocols, grading systems and applications”[Seminars in Arthritis and Rheumatism Volume 75, (2	14
Perioperative management of biologic disease-modifying antirheumatic drugs in patients with inflammatory rheumatic diseases undergoing total joint arthroplasty: A nationwide population-based cohort st	14
Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis	14
Remission in gout is possible: 5-year follow-up in the NOR-Gout study	14
Giant cell arteritis-related stroke in a large inception cohort: A comparative study	14
Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?	14
The natural history of end-stage knee osteoarthritis: Data from the osteoarthritis initiative	13
Hormone therapy in menopause increases rheumatoid arthritis risk: A systematic review and meta-analysis	13
Algorithmic approaches in hand imaging for rheumatic musculoskeletal diseases: A systematic literature review	13
An analysis of the first relapse in giant cell arteritis using ultrasonography	13
Self-esteem, self-concept, and body image of young people with rheumatic and musculoskeletal diseases: A systematic literature review	13
Cognitive impairment and other neuropsychiatric manifestations in patients with primary vasculitis: a systematic review	13
Characteristics and long-term outcomes of patients with rheumatoid arthritis and concurrent calcium pyrophosphate deposition disease	13
Gender influence on ultrasound-assessed therapeutic response in rheumatoid arthritis: Insights from the GENder on UltraSound (GENUS) study	13
Developing efficient predictive models for the diagnosis of VEXAS syndrome	13
Subclinical coronary artery calcification in systemic sclerosis using high-resolution chest CT: Identification, extent, and disease-specific risk factors	13
Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?	13
Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice	13
Predicting best treatment in rheumatoid arthritis	13

Barriers and enablers to the implementation of osteoarthritis management programmes in primary or community care settings: A systematic review and qualitative framework synthesis	13
Hospitalization risk in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A matched cohort study	13
Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis	13
Telemedicine in rheumatology care: A systematic review	12
Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure	12
Giant cell arteritis – New treatment targets at the horizon	12
Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitis	12
Emergency department presentations and hospital admissions for patients with biopsy-positive giant cell arteritis in South Australia	12
Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis	12
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set	12
Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus	12
Risk of new onset of immune-mediated diseases after SARS-CoV-2 infection: A systematic review and meta-analysis	12
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 years	12
Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study	12
Reassessing the prevalence of monophasic, polyphasic and persistent disease courses in still’s disease	12
Aortic disease in giant cell arteritis	12
Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy—A meta-analysis	12
Age of onset of rheumatoid arthritis and radiographic changes	12
How is early spondyloarthritis defined in the literature? Results from a systematic review	12
Minimally invasive interventional procedures for osteoarthritis and inflammatory arthritis: A systematic review and meta-analysis	12
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials	12
Increased incidence of sudden cardiac death in systemic sclerosis: data from a nationwide cohort study	12
Critical commentary: Factors associated with thrombosis in Behçet syndrome: A systematic review and meta-analysis	12
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	12
Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria	12
Diffuse idiopathic skeletal hyperostosis in the oncologic population: a cross-sectional analysis of 1053 patients	12
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study	11
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study	11
COVID-19 vaccination and systemic autoimmune rheumatic diseases: No evidence of disproportionately increased reporting in VAERS	11
Multimodal imaging evaluation of pre-systemic sclerosis patients presenting with Raynaud’s Phenomenon from a reference microcirculatory clinic versus healthy controls: a cross-sectional study	11
Development and validation analysis of a corrected axial spondyloarthritis metrology index (CASMI)	11
Does body mass index mediate the relationship between socioeconomic position and incident osteoarthritis?	11
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence	11
Prevalence of frailty and prefrailty in systemic lupus erythematosus: A systematic review and meta-analysis	11
The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature	11
Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis	11
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options	11
Sodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study	10
[18F]Sodium Fluoride PET has the potential to identify active formation of calcinosis cutis in limited cutaneous systemic sclerosis	10
Sleep disorders in rheumatoid arthritis: Incidence, risk factors and association with dementia	10
The immune pathology of bursitis in rheumatic inflammatory diseases, degenerative conditions and mechanical stress: A systematic review	10
Treatment strategies and outcomes in adult relapsing or refractory cutaneous IgA Vasculitis: A multicenter retrospective cohort study	10
Measurement properties of the decisional conflict scale in people living with chronic non-cancer pain: a secondary analysis of the DECIDE-PAIN pan-Canadian survey	10
Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study	10
Risk of ILD and safety outcomes across DMARD classes in rheumatoid arthritis and RA-ILD	10
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study	10
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity	10
Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	10
Rheumatologist and patient perspectives on axial spondyloarthritis management and treatment satisfaction in Europe	10
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort	10
Comparing Raynaud’s phenomenon attack measurement tools: paper or smartphone application?	10
Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group	10
Diffuse idiopathic skeletal hyperostosis (DISH) and trabecular bone score (TBS) in postmenopausal women: The Camargo cohort	10
Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group	10
Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus	10
Prevalence and risk factors of antinuclear antibodies among pregnant women: A cross-sectional study in Qingdao, China	10
SAPHO syndrome: Patient stratification and the new horizon of precision medicine	10
Macrophages–Autoimmunity–Treatment option	9
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group	9
Comment on "Risk and temporal trends of heart failure subtypes in rheumatoid arthritis"	9
Author Reply to Letter to the Editor	9
Navigating the path of progress: The OMERACT 2023 emerging leaders program	9
Come rain or shine: Is weather a risk factor for musculoskeletal pain? A systematic review with meta-analysis of case-crossover studies	9
Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective	9
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group	9
Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature	9
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies	9
Effects of cumulative lifetime estrogen exposure on the clinical characteristics and courses in postmenopausal women with rheumatoid arthritis	9
Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary center	9
Adipocytokines and achievement of low disease activity in rheumatoid arthritis	9
Evaluation of physical function in patients with inflammatory myopathies using the health assessment questionnaire-II (HAQ-II)	9
Reply on: a meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender	9
Referees	9
Brain white matter microstructural alterations in Behcet's syndrome correlate with cognitive impairment and disease severity: A diffusion tensor imaging study	9
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?	9
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023	9
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review	9
Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties e	9
Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis	9
Evolution of bone lesions in adults with chronic nonbacterial osteitis (CNO): A long-term follow-up study	9
Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States	9
Polygenic risk scores	9
Joint and muscle inflammatory disease: A scoping review of the published evidence	9
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study	9
Healthy dietary pattern and risk of rheumatoid arthritis: A systematic review and meta-analysis	9
Bone and entheseal targets for growth factors in diffuse idiopathic skeletal hyperostosis	9
Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS	9
Corrigendum to The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time [Seminars in Arthritis and Rheumatism Volume 55, 152010]	9
Risk of major adverse cardiovascular events following targeted therapy in patients with rheumatoid arthritis: a real-world analysis stratified by cardiovascular risk	9
Comprehensive analysis of disease activity, neuropsychiatric symptoms, imaging features and risk factors for seizure in hospitalized patients with juvenile-onset neuropsychiatric systemic lupus erythe	9